Computational Methods for Improving Genetic Therapies for Duchene Muscular Dystrophy
Received: 01-Sep-2022 / Manuscript No. jpgb-22-130 / Editor assigned: 05-Sep-2022 / PreQC No. jpgb-22-130(PQ) / Reviewed: 19-Sep-2022 / QC No. jpgb-22-130 / Revised: 26-Sep-2022 / Manuscript No. jpgb-22-130(R) / Published Date: 30-Sep-2022
Abstract
Genetic engineering involves different techniques to intentionally modify genetic material (primarily DNA) in order to alter, restore, or boost shape or function. Established in the late 20th century, recombinant DNA technologies include recombination of different strands of DNA, usually using bacteria (such as Escherichia coli), bacteriophages (such as λ phage) or by way of simple microinjection. In recent years, modern techniques to design and create -literally to engineer- new life forms, typically referred to as synthetic biology, have supplemented these conventional methods [1].
A flexible and efficient gene therapy technique is precision genome editing. The area has been subject to continuous developments since the introduction of CRISPR/Cas systems for genome editing [2]. This new biotechnology technique includes the development of a site-specific double strand break (DSB) accompanied by two key forms of repair mechanisms: non-homologous end-joining and homology directed-repair [3].
In the current work, we broke down and understood the main components of the prime editing technique. An automated approach is required for advancing our understanding of the evolution and diversity of prime editing and for finding new candidates for genome engineering. We used Duchenne Muscular Dystrophy (DMD) as a case study for this proposed approach. More specifically, we applied machine learning algorithms over prime editing data for the genetic disease of DMD. We designed multiple prime editing guide RNAs (pegRNAs) for the potential correction of the mutated exon 44 of DMD gene [4,5].
Biography
Georgios Kargas if affiliated to the Department of Digital Systems, University of Piraeus, Greece. His research interests reflect in his wide range of publications in various national and international journals.
References
- Robert JS, Baylis F (2008) “Genetic engineering,” Int. Encycl Public Heal 35-39.
- Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, et at. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821.
- Anzalone AV (2019) Search-and-replace genome editing without double-strand breaks or donor DNA. Nature.
- Min YL (2019) CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells. Sci. Adv 5.
- Padilha VA, Alkhnbashi OS, Shah SA (2020) CRISPRcasIdentifier: Machine learning for accurate identification and classification of CRISPR-Cas systems. Gigascience 9: 1–12.
Citation: Kargas G, Krithara A, Nentidis A, Palliouras G, Filippakis M (2022) Computational Methods for Improving Genetic Therapies for Duchene Muscular Dystrophy. J Plant Genet Breed 6: 130.
Copyright: © 2022 Kargas G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
黑料网 Journals
Article Usage
- Total views: 630
- [From(publication date): 0-2022 - Nov 22, 2024]
- Breakdown by view type
- HTML page views: 467
- PDF downloads: 163